Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Sun Q, Calderon B, Zhao Z. Discrepancies between two immunoassays for the determination of MPO and PR3 autoantibodies. Clin Chim Acta. 2017;470:93-96.

Gratzinger D, Jaffe ES, Chadburn A, Chan JK, de Jong D, Goodlad JR, et al. Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5. Am J Clin Pathol. 2017;147(2):204-216.

Tsang HC, Bussel JB, Mathew S, Liu Y-, Imahiyerobo AA, Orazi A, et al. Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases. Mod Pathol. 2017;30(4):486-498.

Cybulska P, Goss C, Tew WP, Parameswaran R, Sonoda Y. Indications for and complications of transfusion and the management of gynecologic malignancies. Gynecol Oncol. 2017;146(2):416-426.

2016

Sanchez T. Sphingosine-1-Phosphate Signaling in Endothelial Disorders. Curr Atheroscler Rep. 2016;18(6):31.

Evans JR, Zhao SG, S Chang L, Tomlins SA, Erho N, Sboner A, et al. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer. JAMA Oncol. 2016;2(4):471-80.

Westblade LF, van Belkum A, Grundhoff A, Weinstock GM, Pamer EG, Pallen MJ, et al. Role of Clinicogenomics in Infectious Disease Diagnostics and Public Health Microbiology. J Clin Microbiol. 2016;54(7):1686-1693.

Collins JP, Westblade LF, Anderson EJ. Gram-Positive Diplococci in a Cerebrospinal Fluid Gram Stain. Open Forum Infect Dis. 2016;3(4):ofw206.

Graff RE, Meisner A, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, et al. Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression. Br J Cancer. 2016;114(8):939-44.

Mehra R, Udager AM, Ahearn TU, Cao X, Feng FY, Loda M, et al. Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer. Eur Urol. 2016;70(4):549-552.